Exir Nano Sina Company is the producer of the first injectable Anti-Cancer Nano drug at Middle East. It has founded with the support of Iranian Nanotechnology Initiative Council in 2009.
Exir Nano Sina Company (ENSC) is a knowledge-based Nano pharmaceutical company focused on the research, development and commercialization of innovative Nano pharmaceutical products based on its proprietary drug delivery technologies.
ENSC strives to become a local and global leading Nano pharmaceutical company, to contribute more towards making a difference in the healthcare industry and make Iranian nanotechnology industry visible in the global arena.
ENSC is dedicated to maximizing the benefits of medications for patients and improving their quality of life through constantly advancing our technology & know-how.